Susceptibility to exogenously added interferon-β protein depends on intracellular interferon-β mRNA level in human glioma cells

Cytokine

Volumn 32, Issue 5, 2005, Pages 240-245

  Osawa, Hirokatsu ^a   Mizuno, Masaaki ^a   Hatano, Manabu ^a   Nakahara, Norimoto ^a   Tsuno, Takaya ^a   Kuno, Tomohiko ^a   Endo, Masato ^a   Yoshida, Jun ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiproliferative effect; Human interferon (HuIFN) ; siRNA for HuIFN

Indexed keywords

BETA INTERFERON; HUMAN INTERFERON; MESSENGER RNA; SMALL INTERFERING RNA;

ARTICLE; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; INTERFERON INDUCERS; INTERFERON-BETA; MELANOMA; POLY I-C; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 31344449940     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2005.10.003     Document Type: Article

References (30)

1. G.R. Stark, I.M. Kerr, B.R. Williams, R.H. Silverman, and R.D. Schreiber How cells respond to interferons Annu Rev Biochem 67 1998 227 264
2. R.S. Dick, and H.R. Hubbell Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations J Neurooncol 5 1987 331 338
3. M. Chawla Sarkar, D.W. Leaman, and E.C. Borden Preferential induction of apoptosis by interferon (IFN)-β compared with IFN-α: correlation with TRAIL/Apo2L induction in melanoma cell lines Clin Cancer Res 7 2001 1821 1831
4. B.H. Morrison, J.A. Bauer, D.V. Kalvakolanu, and D.J. Lindner Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-β in ovarian carcinoma cells J Biol Chem 276 2001 24965 24970
5. Q. Chen, B. Gong, A.S. Mahmoud Ahmed, A. Zhou, and E.D. Hsi Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma Blood 98 2001 2183 2192
6. J. Yoshida, Y. Kajita, T. Wakabayashi, and K. Sugita Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation Acta Neurochir (Wien) 127 1994 55 59
7. M. Mizuno, J. Yoshida, K. Sugita, I. Inoue, H. Seo, and Y. Hayashi Growth inhibition of glioma cells transfected with the human β-interferon gene by liposomes coupled with a monoclonal antibody Cancer Res 50 1990 7826 7829
8. M. Mizuno, J. Yoshida, H. Oyama, and K. Sugita Growth inhibition of glioma cells by liposome-mediated cell transfection with tumor necrosis factor-α gene: its enhancement by prior γ-interferon treatment Neurol Med Chir (Tokyo) 32 1992 873 876
9. M. Mizuno, and J. Yoshida Effect of human interferon-β gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells Cancer Immunol Immunother 47 1998 227 232
10. A. Natsume, M. Mizuno, Y. Ryuke, and J. Yoshida Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse Gene Ther 6 1999 1626 1633
11. A. Natsume, K. Tsujimura, M. Mizuno, T. Takahashi, and J. Yoshida IFN-β gene therapy induces systemic antitumor immunity against malignant glioma J Neurooncol 47 2000 117 124
12. K. Yagi, Y. Hayashi, N. Ishida, M. Ohbayashi, N. Ohishi, and M. Mizuno Interferon-β endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain Biochem Mol Biol Int 32 1994 167 171
13. J. Yoshida, M. Mizuno, and K. Yagi Efficient transfection of human interferon-β gene to human glioma cells by means of cationic multilamellar liposomes coupled with a monoclonal antibody J Neurooncol 19 1994 269 274
14. T. Kageshita, M. Mizuno, T. Ono, K. Matsumoto, T. Saida, and J. Yoshida Growth inhibition of human malignant melanoma transfected with the human interferon-β gene by means of cationic liposomes Melanoma Res 11 2001 337 342
15. H. Nakanishi, Y. Mizutani, A. Kawauchi, O. Ukimura, T. Shiraishi, and M. Hatano Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-β gene against human renal cell carcinoma Clin Cancer Res 9 2003 1129 1135
16. B.S. Kuhne, and P. Oschmann Quantitative real-time RT-PCR using hybridization probes and imported standard curves for cytokine gene expression analysis Biotechniques 33 1078 2002 1072 1080
17. I. Inoue, J. Yoshida, M. Nagata, M. Mizuno, H. Seo, and N. Matsui Superinduction of cytotoxic interferon-β in glioma cells Neurol Med Chir (Tokyo) 31 1991 485 489
18. T. Wakabayashi, J. Yoshida, T. Kobayashi, N. Kageyama, and M. Kanzaki Effect of interferon on malignant brain tumor Gan To Kagaku Ryoho 9 1982 1400 1406
19. J. Yoshida, T. Wakabayashi, I. Inoue, and N. Kageyama Combination therapy with HU IFN-β and ACNU against malignant brain tumors, Part 1. Experimental study in vitro Gan To Kagaku Ryoho 12 1985 99 104
20. J. Yoshida, M. Mizuno, M. Fujii, Y. Kajita, N. Nakahara, and M. Hatano Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon-β gene using cationic liposomes Hum Gene Ther 15 2004 77 86
21. J.J. O'Shea, M. Gadina, and R.D. Schreiber Cytokine signaling in 2002: new surprises in the Jak/Stat pathway Cell 109 Suppl 2002 S121 S131
22. M. Sato, N. Hata, M. Asagiri, T. Nakaya, T. Taniguchi, and N. Tanaka Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7 FEBS Lett 441 1998 106 110
23. A. Kroger, M. Koster, K. Schroeder, H. Hauser, and P.P. Mueller Activities of IRF-1 J Interferon Cytokine Res 22 2002 5 14
24. J.E. Darnell Jr., I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
25. R. Lu, W.C. Au, W.S. Yeow, N. Hageman, and P.M. Pitha Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon and silencing by hypermethylation J Biol Chem 275 2000 31805 31812
26. H. Satomi, B. Wang, H. Fujisawa, and F. Otsuka Interferon-β from melanoma cells suppresses the proliferations of melanoma cells in an autocrine manner Cytokine 18 2002 108 115
27. A. Pansky, P. Hildebrand, E. Fasler Kan, L. Baselgia, S. Ketterer, and C. Beglinger Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-α Int J Cancer 85 2000 720 725
28. L.H. Wong, K.G. Krauer, I. Hatzinisiriou, M.J. Estcourt, P. Hersey, and N.D. Tam Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3γ J Biol Chem 272 1997 28779 28785
29. A. Takaoka, S. Hayakawa, H. Yanai, D. Stoiber, H. Negishi, and H. Kikuchi Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence Nature 424 2003 516 523
30. K.H. Vousden, and X. Lu Live or let die: the cell's response to p53 Nat Rev Cancer 2 2002 594 604